AAPL346.95+3.04 (+0.88%) ▲|ABBV286.48-0.26 (-0.09%) ▼|ABT103.40-1.48 (-1.41%) ▼|ACN236.25-10.98 (-4.44%) ▼|ADBE251.12-7.50 (-2.90%) ▼|AMAT398.08+10.49 (+2.71%) ▲|AMD558.56+27.28 (+5.13%) ▲|AMGN447.01+2.38 (+0.53%) ▲|AMT185.93-2.35 (-1.25%) ▼|AMZN253.31+4.22 (+1.69%) ▲|AVGO341.61+12.44 (+3.78%) ▲|AXP314.18-0.88 (-0.28%) ▼|BA169.85-18.46 (-9.80%) ▼|BAC50.60+0.08 (+0.16%) ▲|BKNG151.78-1.36 (-0.89%) ▼|BLK1,134.93+7.27 (+0.64%) ▲|BMY61.34-0.27 (-0.44%) ▼|BNY147.83+0.65 (+0.44%) ▲|BRK-B544.77-3.79 (-0.69%) ▼|C122.63+1.59 (+1.31%) ▲|CAT712.52+20.39 (+2.95%) ▲|CL92.17-0.94 (-1.00%) ▼|CMCSA21.88-0.18 (-0.79%) ▼|COF204.42+2.07 (+1.02%) ▲|COP148.36-3.01 (-1.99%) ▼|COST991.31-13.86 (-1.38%) ▼|CRM243.11-4.51 (-1.82%) ▼|CSCO112.51+2.27 (+2.05%) ▲|CVS91.79-0.74 (-0.80%) ▼|CVX228.00-4.01 (-1.73%) ▼|DE642.51+1.26 (+0.20%) ▲|DHR232.24-0.73 (-0.31%) ▼|DIS109.57-0.83 (-0.75%) ▼|DUK124.02-0.42 (-0.33%) ▼|EMR164.59+2.89 (+1.79%) ▲|FDX304.59+4.01 (+1.33%) ▲|GD356.19-0.86 (-0.24%) ▼|GE295.92+7.49 (+2.60%) ▲|GEV878.92+24.30 (+2.84%) ▲|GILD157.49-1.21 (-0.76%) ▼|GM81.00+4.69 (+6.15%) ▲|GOOG318.16+3.97 (+1.26%) ▲|GOOGL321.77+4.97 (+1.57%) ▲|GS913.08+19.80 (+2.22%) ▲|HD318.22-1.16 (-0.36%) ▼|HON217.13-2.15 (-0.98%) ▼|IBM249.61-3.83 (-1.51%) ▼|INTC93.99+3.52 (+3.89%) ▲|INTU327.03-12.86 (-3.78%) ▼|ISRG444.77-6.86 (-1.52%) ▼|JNJ267.72+1.42 (+0.53%) ▲|JPM336.11+2.07 (+0.62%) ▲|KO92.13-0.57 (-0.61%) ▼|LIN506.81-0.75 (-0.15%) ▼|LLY1,284.53+5.39 (+0.42%) ▲|LMT628.47-6.73 (-1.06%) ▼|LOW197.14-1.09 (-0.55%) ▼|LRCX241.03+3.53 (+1.49%) ▲|MA610.28-3.22 (-0.52%) ▼|MCD248.78-2.06 (-0.82%) ▼|MDLZ62.30-0.67 (-1.06%) ▼|MDT93.80-0.99 (-1.04%) ▼|META624.85-5.71 (-0.91%) ▼|MMM171.51-1.28 (-0.74%) ▼|MO73.36-0.26 (-0.35%) ▼|MRK142.17+1.56 (+1.11%) ▲|MS187.21+3.72 (+2.03%) ▲|MSFT533.73+1.13 (+0.21%) ▲|MU931.42+27.72 (+3.07%) ▲|NEE82.05+0.01 (+0.01%) ▲|NFLX62.71-1.19 (-1.86%) ▼|NKE37.46-0.46 (-1.20%) ▼|NOW155.95-2.24 (-1.41%) ▼|NVDA218.70+2.70 (+1.25%) ▲|ORCL131.76+5.70 (+4.52%) ▲|PEP133.87-1.59 (-1.17%) ▼|PFE29.72-0.08 (-0.25%) ▼|PG158.48-1.44 (-0.90%) ▼|PLTR201.02+2.18 (+1.10%) ▲|PM203.69+1.82 (+0.90%) ▲|QCOM181.20+1.60 (+0.89%) ▲|RTX195.90-1.58 (-0.80%) ▼|SBUX102.49-0.21 (-0.20%) ▼|SCHW89.61-0.12 (-0.13%) ▼|SO91.87-0.70 (-0.76%) ▼|SPG212.30-0.40 (-0.19%) ▼|T21.07+0.22 (+1.03%) ▲|TMO692.74+7.85 (+1.15%) ▲|TMUS146.97+0.04 (+0.03%) ▲|TSLA406.15+14.53 (+3.71%) ▲|TXN306.47+8.35 (+2.80%) ▲|UBER66.13+0.00 (+0.00%) ▲|UNH409.51-1.20 (-0.29%) ▼|UNP297.85+0.88 (+0.29%) ▲|UPS103.36+3.04 (+3.03%) ▲|USB59.74+0.04 (+0.06%) ▲|V400.76-3.40 (-0.84%) ▼|VZ43.84+0.74 (+1.72%) ▲|WFC82.61-0.04 (-0.05%) ▼|WMT118.94-1.36 (-1.13%) ▼|XOM181.09-3.46 (-1.87%) ▼|AAPL346.95+3.04 (+0.88%) ▲|ABBV286.48-0.26 (-0.09%) ▼|ABT103.40-1.48 (-1.41%) ▼|ACN236.25-10.98 (-4.44%) ▼|ADBE251.12-7.50 (-2.90%) ▼|AMAT398.08+10.49 (+2.71%) ▲|AMD558.56+27.28 (+5.13%) ▲|AMGN447.01+2.38 (+0.53%) ▲|AMT185.93-2.35 (-1.25%) ▼|AMZN253.31+4.22 (+1.69%) ▲|AVGO341.61+12.44 (+3.78%) ▲|AXP314.18-0.88 (-0.28%) ▼|BA169.85-18.46 (-9.80%) ▼|BAC50.60+0.08 (+0.16%) ▲|BKNG151.78-1.36 (-0.89%) ▼|BLK1,134.93+7.27 (+0.64%) ▲|BMY61.34-0.27 (-0.44%) ▼|BNY147.83+0.65 (+0.44%) ▲|BRK-B544.77-3.79 (-0.69%) ▼|C122.63+1.59 (+1.31%) ▲|CAT712.52+20.39 (+2.95%) ▲|CL92.17-0.94 (-1.00%) ▼|CMCSA21.88-0.18 (-0.79%) ▼|COF204.42+2.07 (+1.02%) ▲|COP148.36-3.01 (-1.99%) ▼|COST991.31-13.86 (-1.38%) ▼|CRM243.11-4.51 (-1.82%) ▼|CSCO112.51+2.27 (+2.05%) ▲|CVS91.79-0.74 (-0.80%) ▼|CVX228.00-4.01 (-1.73%) ▼|DE642.51+1.26 (+0.20%) ▲|DHR232.24-0.73 (-0.31%) ▼|DIS109.57-0.83 (-0.75%) ▼|DUK124.02-0.42 (-0.33%) ▼|EMR164.59+2.89 (+1.79%) ▲|FDX304.59+4.01 (+1.33%) ▲|GD356.19-0.86 (-0.24%) ▼|GE295.92+7.49 (+2.60%) ▲|GEV878.92+24.30 (+2.84%) ▲|GILD157.49-1.21 (-0.76%) ▼|GM81.00+4.69 (+6.15%) ▲|GOOG318.16+3.97 (+1.26%) ▲|GOOGL321.77+4.97 (+1.57%) ▲|GS913.08+19.80 (+2.22%) ▲|HD318.22-1.16 (-0.36%) ▼|HON217.13-2.15 (-0.98%) ▼|IBM249.61-3.83 (-1.51%) ▼|INTC93.99+3.52 (+3.89%) ▲|INTU327.03-12.86 (-3.78%) ▼|ISRG444.77-6.86 (-1.52%) ▼|JNJ267.72+1.42 (+0.53%) ▲|JPM336.11+2.07 (+0.62%) ▲|KO92.13-0.57 (-0.61%) ▼|LIN506.81-0.75 (-0.15%) ▼|LLY1,284.53+5.39 (+0.42%) ▲|LMT628.47-6.73 (-1.06%) ▼|LOW197.14-1.09 (-0.55%) ▼|LRCX241.03+3.53 (+1.49%) ▲|MA610.28-3.22 (-0.52%) ▼|MCD248.78-2.06 (-0.82%) ▼|MDLZ62.30-0.67 (-1.06%) ▼|MDT93.80-0.99 (-1.04%) ▼|META624.85-5.71 (-0.91%) ▼|MMM171.51-1.28 (-0.74%) ▼|MO73.36-0.26 (-0.35%) ▼|MRK142.17+1.56 (+1.11%) ▲|MS187.21+3.72 (+2.03%) ▲|MSFT533.73+1.13 (+0.21%) ▲|MU931.42+27.72 (+3.07%) ▲|NEE82.05+0.01 (+0.01%) ▲|NFLX62.71-1.19 (-1.86%) ▼|NKE37.46-0.46 (-1.20%) ▼|NOW155.95-2.24 (-1.41%) ▼|NVDA218.70+2.70 (+1.25%) ▲|ORCL131.76+5.70 (+4.52%) ▲|PEP133.87-1.59 (-1.17%) ▼|PFE29.72-0.08 (-0.25%) ▼|PG158.48-1.44 (-0.90%) ▼|PLTR201.02+2.18 (+1.10%) ▲|PM203.69+1.82 (+0.90%) ▲|QCOM181.20+1.60 (+0.89%) ▲|RTX195.90-1.58 (-0.80%) ▼|SBUX102.49-0.21 (-0.20%) ▼|SCHW89.61-0.12 (-0.13%) ▼|SO91.87-0.70 (-0.76%) ▼|SPG212.30-0.40 (-0.19%) ▼|T21.07+0.22 (+1.03%) ▲|TMO692.74+7.85 (+1.15%) ▲|TMUS146.97+0.04 (+0.03%) ▲|TSLA406.15+14.53 (+3.71%) ▲|TXN306.47+8.35 (+2.80%) ▲|UBER66.13+0.00 (+0.00%) ▲|UNH409.51-1.20 (-0.29%) ▼|UNP297.85+0.88 (+0.29%) ▲|UPS103.36+3.04 (+3.03%) ▲|USB59.74+0.04 (+0.06%) ▲|V400.76-3.40 (-0.84%) ▼|VZ43.84+0.74 (+1.72%) ▲|WFC82.61-0.04 (-0.05%) ▼|WMT118.94-1.36 (-1.13%) ▼|XOM181.09-3.46 (-1.87%) ▼|
14.6 C
New York
Tuesday, October 27, 2026

Tag: cause

newsFORsourcecompanycontentinformation1releasesmarket

Borr Drilling Limited – Prospector 5 Rig Incident Update

HAMILTON, Bermuda, Oct. 26, 2026 /PRNewswire/ -- Borr Drilling Limited (NYSE: BORR) (OSE: BORR) ("Borr Drilling") provides an update on the Prospector 5 incident offshore...

Antengene Presents Latest Clinical Results for ATG-022 and ATG-037 at ESMO 2026

SHANGHAI and HONG KONG, Oct. 26, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to...

Antengene Presents Latest Clinical Results for ATG-022 and ATG-037 at ESMO 2026

SHANGHAI and HONG KONG, Oct. 25, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to...

RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancer

Responses were deep and durable, with 65% ongoing at clinical cutoffResults support continued evaluation of the investigational RYBREVANT FASPRO regimen in the ongoing first-line Phase...

New data on Lilly’s investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-mutant non-small cell lung cancer

Data presented at ESMO highlight the promising efficacy of olomorasib in combination with standard-of-care immunotherapy with or without chemotherapy in first-line advanced KRAS G12C-mutant...

Stadium-sized support for wildlife at WWF-Canada’s biggest BC Place Climb for Nature

 The third annual event raised $122,000, pushing 2026's national Climb for Nature total to $1.6 million VANCOUVER, BC, Oct. 24, 2026 /CNW/ -- A record...

IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER

Nearly 80% of Patients Were Alive at One Year Versus 53% with IMFINZI Alone and Progression-Free Survival More Than TripledLate-Breaking Phase 3 DeLLphi-305 Results Presented in...

In HelloNation, Insurance Expert Devery Prince Breaks Down Affordable Insurance in Alaska

The Article Explains How Choosing the Right Coverage Matters More for Alaska Residents Than Simply Finding the Lowest Premium.ANCHORAGE, Alaska, Oct. 24, 2026 /PRNewswire/...

Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk...

New substudy results showed a 51% lower estimated risk of metastasis or death over time with perioperative apalutamide plus ADT compared with immediate surgeryTwice as...

Lilly presents first clinical data in platinum-sensitive ovarian cancer for its investigational, next-generation, FRα-targeting ADC at ESMO 2026

Sofetabart mipitecan (Sofe-M) in combination with bevacizumab demonstrated a 79% confirmed objective response rate and 100% disease control rate, with similar activity observed across...

Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development

Research Will Use Lunit's AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Generate Scalable Insights into Tumor Microenvironment BiologySEOUL, South Korea, Oct. 24,...

DENARIUS METALS FILES TORAL PROJECT TECHNICAL REPORT ON SEDAR+

TORONTO, Oct. 23, 2026 /CNW/ -- Denarius Metals Corp. (Cboe CA: DMET) (OTCQX: DNRSF) ("Denarius Metals" or "the Company") announced today the filing of...

DENARIUS METALS FILES TORAL PROJECT TECHNICAL REPORT ON SEDAR+

TORONTO, Oct. 23, 2026 /PRNewswire/ -- Denarius Metals Corp. (Cboe CA: DMET) (OTCQX: DNRSF) ("Denarius Metals" or "the Company") announced today the filing of...

NEXT PROPERTIES ANNOUNCES RESULTS OF EXCHANGE OFFERS FOR ANY & ALL OF ITS OUTSTANDING 6.950% SENIOR NOTES DUE 2044 AND 6.390% SENIOR NOTES DUE...

MEXICO CITY, Oct. 23, 2026 /PRNewswire/ -- NEXT Properties (Trust 2401), a trust formed under the laws of the United Mexican States (the "Trust"...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCause

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers